Albumin in the nephrotic syndrome

BMJ 1995; 310 doi: https://doi.org/10.1136/bmj.310.6990.1333a (Published 20 May 1995) Cite this as: BMJ 1995;310:1333
  1. D W Eadington,
  2. W D Plant,
  3. R J Winney
  1. Senior registrar Research fellow Consultant renal physician Department of Renal Medicine, Royal Infirmary, Edinburgh EH3 9YW

    EDITOR,—We challenge Fehmi Akcicek and colleagues' argument against the use of albumin in the nephrotic syndrome on two counts.1 The first concerns the selection of patients. The urinary protein loss, plasma creatinine concentration, and prior drug treatment are not given in their report, but we assume that the patients had not received either corticosteroids or diuretics. The mean excretion of 2.96 litres of water and 275 mmol of sodium after intravenous frusemide, implying weight loss of about …

    View Full Text

    Log in

    Log in through your institution


    * For online subscription